- Home
- TMDX vs PCVX Comparison
TMDX vs PCVX Comparison
Compare TMDX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- PCVX
- Stock Information
- Founded
- TMDX 1998
- PCVX 2013
- Country
- TMDX United States
- PCVX United States
- Employees
- TMDX N/A
- PCVX N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TMDX Health Care
- PCVX Health Care
- Exchange
- TMDX Nasdaq
- PCVX Nasdaq
- Market Cap
- TMDX 3.9B
- PCVX 6.0B
- IPO Year
- TMDX 2019
- PCVX 2020
- Fundamental
- Price
- TMDX $114.30
- PCVX $49.03
- Analyst Decision
- TMDX Buy
- PCVX Strong Buy
- Analyst Count
- TMDX 11
- PCVX 7
- Target Price
- TMDX $130.73
- PCVX $101.67
- AVG Volume (30 Days)
- TMDX 1.0M
- PCVX 1.4M
- Earning Date
- TMDX 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- TMDX N/A
- PCVX N/A
- EPS Growth
- TMDX 170.70
- PCVX N/A
- EPS
- TMDX 2.54
- PCVX N/A
- Revenue
- TMDX $566,354,000.00
- PCVX N/A
- Revenue This Year
- TMDX $38.84
- PCVX N/A
- Revenue Next Year
- TMDX $20.46
- PCVX N/A
- P/E Ratio
- TMDX $45.35
- PCVX N/A
- Revenue Growth
- TMDX 41.20
- PCVX N/A
- 52 Week Low
- TMDX $55.00
- PCVX $27.66
- 52 Week High
- TMDX $145.50
- PCVX $98.17
- Technical
- Relative Strength Index (RSI)
- TMDX 40.85
- PCVX 69.14
- Support Level
- TMDX $115.21
- PCVX $40.14
- Resistance Level
- TMDX $125.57
- PCVX $45.90
- Average True Range (ATR)
- TMDX 7.65
- PCVX 2.30
- MACD
- TMDX -1.72
- PCVX 0.26
- Stochastic Oscillator
- TMDX 12.41
- PCVX 91.15
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.